{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:03:57Z","timestamp":1785492237774,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00892-3","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T03:32:45Z","timestamp":1778383965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Viral suppression status and associated factors among key populations on ART in Western Oromia, Ethiopia: a retrospective analysis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7431-7435","authenticated-orcid":false,"given":"Kenate","family":"Bekele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6082-0703","authenticated-orcid":false,"given":"Endalu Tesfaye","family":"Guteta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0898-6646","authenticated-orcid":false,"given":"Abdi","family":"Diriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gadisa","family":"Chewaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demeke","family":"Jabessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Amsalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"issue":"12","key":"892_CR1","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","volume":"11","author":"A Carter","year":"2024","unstructured":"Carter A, Zhang M, Tram KH, Walters MK, Jahagirdar D, Brewer ED, et al. Global, regional, and national burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. Lancet HIV. 2024;11(12):e807\u201322.","journal-title":"Lancet HIV"},{"issue":"11","key":"892_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2666-5247(24)00151-4","volume":"5","author":"M Nair","year":"2024","unstructured":"Nair M, Gettins L, Fuller M, Kirtley S, Hemelaar J. Global and regional genetic diversity of HIV-1 in 2010\u201321: systematic review and analysis of prevalence. Lancet Microbe. 2024;5(11):1\u201312.","journal-title":"Lancet Microbe"},{"issue":"11","key":"892_CR3","first-page":"10","volume":"9","author":"J Ayieko","year":"2024","unstructured":"Ayieko J, Thorp M, Ghebremichael M. Renewing Our Focus on Vulnerable Populations Among People Living with HIV. Trop Med Infect Dis. 2024;9(11):10\u20133.","journal-title":"Trop Med Infect Dis"},{"issue":"51","key":"892_CR4","first-page":"1","volume":"22","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li AD, Yang Y, Lu J, Xu Y, Ji X, et al. Global, regional and national burden of HIV\/AIDS among individuals aged 15\u201379 from 1990 to 2021. AIDS Res Ther. 2025;22(51):1\u201311.","journal-title":"AIDS Res Ther"},{"issue":"1068","key":"892_CR5","first-page":"1","volume":"24","author":"AA Berhane","year":"2024","unstructured":"Berhane AA, Chimdesa HF, Awedew AF, Bekele NA, Teferi HM, W\/Yohannes G. Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia. BMC Infect Dis. 2024;24(1068):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"892_CR6","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1097\/QAI.0000000000003340","volume":"95","author":"EL Korenromp","year":"2024","unstructured":"Korenromp EL, Sabin K, Stover J, Brown T, Johnson LF, Martin-Hughes R, et al. New HIV Infections among Key Populations and Their Partners in 2010 and 2022, by World Region: a Multisources Estimation. J Acquir Immune Defic Syndr. 2024;95(1):E34\u201345.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"892_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.7196\/SAMJnew.7918","volume":"105","author":"O Shisana","year":"2015","unstructured":"Shisana O, Zungu N, Evans M, Risher K, Rehle T, Celentano D. The case for expanding the definition of \u2018key populations\u2019 to include high-risk groups in the general population to improve targeted HIV prevention efforts. South Afr Med J. 2015;105(8):664\u20139.","journal-title":"South Afr Med J"},{"issue":"14","key":"892_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1097\/QAD.0000000000003692","volume":"37","author":"MC Freeman","year":"2023","unstructured":"Freeman MC, Wainberg ML, Slabbert JD, Mabela S, Wolvaardt G. Persons with severe mental health conditions should be included as a key population in HIV programmes. Aids. 2023;37(14):2115\u20138.","journal-title":"Aids"},{"key":"892_CR9","first-page":"1","volume":"11","author":"E Moyo","year":"2023","unstructured":"Moyo E, Moyo P, Murewanhema G, Mhango M, Chitungo I, Dzinamarira T. Key populations and Sub-Saharan Africa\u2019s HIV response. Front Public Heal. 2023;11:1\u20134.","journal-title":"Front Public Heal"},{"key":"892_CR10","unstructured":"WHO. Hiv Strategic Information for Impact Driving Impact Through Programme Monitoring. 2020. p. 1\u2013176."},{"issue":"5","key":"892_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3851\/IMP3371","volume":"25","author":"T Pillay","year":"2020","unstructured":"Pillay T, Cornell M, Fox MP, Euvrard J, Fatti G, Technau KG, et al. Recording of HIV viral loads and viral suppression in South African patients receiving antiretroviral treatment: a multicentre cohort study. Antivir Ther. 2020;25(5):257\u201366.","journal-title":"Antivir Ther"},{"issue":"390","key":"892_CR12","first-page":"1","volume":"24","author":"MS Kahabuka","year":"2024","unstructured":"Kahabuka MS, Woldeamanuel Y, Mbelele PM, Mpolya EA, Mpagama SG, Kessy JP, et al. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania. BMC Infect Dis. 2024;24(390):1\u201311.","journal-title":"BMC Infect Dis"},{"key":"892_CR13","first-page":"1","volume":"13","author":"P Wakooko","year":"2020","unstructured":"Wakooko P, Gavamukulya Y, Wandabwa JN. Viral load Suppression and Associated Factors among HIV Patients on Antiretroviral Treatment in Bulambuli District, Eastern Uganda: A Retrospective Cohort Study. Infect Dis Res Treat. 2020;13:1\u20139.","journal-title":"Infect Dis Res Treat"},{"issue":"476","key":"892_CR14","first-page":"1","volume":"13","author":"O Barry","year":"2013","unstructured":"Barry O, Powell J, Renner L, Bonney EY, Prin M, Ampofo W, et al. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana. BMC Infect Dis. 2013;13(476):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"892_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1293.2008.00650.x","volume":"10","author":"CJ Smith","year":"2009","unstructured":"Smith CJ, Phillips AN, Dauer B, Johnson MA, Lampe FC, Youle MS, et al. Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression. HIV Med. 2009;10(1):19\u201327.","journal-title":"HIV Med"},{"issue":"21","key":"892_CR16","first-page":"1","volume":"19","author":"S Opoku","year":"2022","unstructured":"Opoku S, Sakyi SA, Ayisi-Boateng NK, Enimil AK, Senu E, Ansah RO, et al. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana. AIDS Res Ther. 2022;19(21):1\u201310.","journal-title":"AIDS Res Ther"},{"key":"892_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2020.05.097","volume":"97","author":"EK Maina","year":"2020","unstructured":"Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151\u20138.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"892_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1086\/321900","volume":"33","author":"CM Kitchen","year":"2001","unstructured":"Kitchen CM, Kitchen SG, Dubin JA, Gottlieb MS. Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. Clin Infect Dis. 2001;33(4):466\u201372.","journal-title":"Clin Infect Dis"},{"key":"892_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/HIV.S139516","volume":"9","author":"B Bayu","year":"2017","unstructured":"Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV\/AIDS - Res Palliat Care. 2017;9:153\u20139.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"issue":"9","key":"892_CR20","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/jac\/dkv143","volume":"70","author":"M Rup\u00e9rez","year":"2015","unstructured":"Rup\u00e9rez M, Pou C, Maculuve S, Cede\u00f1o S, Luis L, Rodr\u00edguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639\u201347.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"892_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/sextrans-2013-051353","volume":"90","author":"DA Tran","year":"2014","unstructured":"Tran DA, Wilson DP, Shakeshaft A, Ngo AD, Doran C, Zhang L. Determinants of virological failure after 1 year\u2019s antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces. Sex Transm Infect. 2014;90(7):538\u201344.","journal-title":"Sex Transm Infect"},{"key":"892_CR22","first-page":"1","volume":"18","author":"TO Labisi","year":"2022","unstructured":"Labisi TO, Podany AT, Fadul NA, Coleman JD, King KM. Factors associated with viral suppression among cisgender women living with human immunodeficiency virus in the United States: an integrative review. Women\u2019s Heal. 2022;18:1\u201313.","journal-title":"Women\u2019s Heal"},{"issue":"3","key":"892_CR23","first-page":"1","volume":"2020","author":"SY Lokpo","year":"2020","unstructured":"Lokpo SY, Ofori-Attah PJ, Ameke LS, Obirikorang C, Orish VN, Kpene GE, et al. Viral Suppression and Its Associated Factors in HIV Patients on Highly Active Antiretroviral Therapy (HAART): a Retrospective Study in the Ho Municipality, Ghana. AIDS Res Treat. 2020;2020(3):1\u20137.","journal-title":"AIDS Res Treat"},{"issue":"02","key":"892_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4236\/wja.2022.122004","volume":"12","author":"L Bulage","year":"2022","unstructured":"Bulage L, Akimana B, Namuli JD, Musisi S, Birungi J, Etukoit M, et al. Risk Factors for Viral Non-Suppression among People Living with HIV and Major Depressive Disorder in Uganda. World J AIDS. 2022;12(02):43\u201354.","journal-title":"World J AIDS"},{"issue":"1","key":"892_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12199-020-00881-6","volume":"25","author":"M Melku","year":"2020","unstructured":"Melku M, Abebe G, Teketel A, Asrie F, Yalew A, Biadgo B, et al. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy. Environ Health Prev Med. 2020;25(1):1\u20139.","journal-title":"Environ Health Prev Med"},{"issue":"4","key":"892_CR26","first-page":"1","volume":"20","author":"AA Desta","year":"2020","unstructured":"Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(4):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"448","key":"892_CR27","first-page":"1","volume":"21","author":"S Qin","year":"2021","unstructured":"Qin S, Lai J, Zhang H, Wei D, Lv Q, Pan X, et al. Predictive factors of viral load high-risk events for virological failure in HIV\/AIDS patients receiving long-term antiviral therapy. BMC Infect Dis. 2021;21(448):1\u201311.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"892_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0270855","volume":"17","author":"TP Gordon","year":"2022","unstructured":"Gordon TP, Talbert M, Mugisha MK, Herbert AE. Factors associated with HIV viral suppression among adolescents in Kabale district, South Western Uganda. PLoS ONE. 2022;17(8):1\u201320.","journal-title":"PLoS ONE"},{"key":"892_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/HIV.S408565","volume":"15","author":"E Erjino","year":"2023","unstructured":"Erjino E, Abera E, Tirore LL. Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia. HIV\/AIDS - Res Palliat Care. 2023;15:157\u201371.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"key":"892_CR30","first-page":"1","volume":"13","author":"A Lamesa","year":"2025","unstructured":"Lamesa A, Teshoma S, Oljira Desta H, Regassa BT, Waqkene T. Prevalence of virological failure and associated factors among adult individuals on highly active antiretroviral treatment (HAART) in public health facilities at Tulu Bolo Town, Southwest Shoa, Ethiopia, 2024. Front Public Heal. 2025;13:1\u201310.","journal-title":"Front Public Heal"},{"issue":"1","key":"892_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0313481","volume":"20","author":"TA Kitaw","year":"2025","unstructured":"Kitaw TA, Haile RN. Virological outcomes of antiretroviral therapy and its determinants among HIV patients in Ethiopia: implications for achieving the 95-95-95 target. PLoS ONE. 2025;20(1):1\u201311.","journal-title":"PLoS ONE"},{"issue":"1","key":"892_CR32","first-page":"1","volume":"13","author":"FJ Louis","year":"2018","unstructured":"Louis FJ, Buteau J, Fran\u00e7ois K, Hulland E, Domer\u00e7ant JW, Yang C, et al. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti. PLoS ONE. 2018;13(1):1\u201312.","journal-title":"PLoS ONE"},{"issue":"2","key":"892_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/aam.aam_42_23","volume":"23","author":"IA Ogunyinka","year":"2024","unstructured":"Ogunyinka IA, Shaibu RO, Abubakar K, Yahaya M, Chukwudi UE, Usman ML, et al. Predictors of Viral Suppression among Adults Living with HIV\/AIDS in Nigeria: a Retrospective Chart Review. Ann Afr Med. 2024;23(2):125\u201331.","journal-title":"Ann Afr Med"},{"issue":"1","key":"892_CR34","first-page":"73","volume":"19","author":"NV Abdagire","year":"2025","unstructured":"Abdagire NV, Totewad RM, Lomte AA, Jadhav AG, Boinwad AS, Mundhe BA, et al. Correlation of Viral Load Suppression and Associated Factors Among HIV Patients on Antiretroviral Therapy in a Tertiary Care Hospital. MakhillpublicationsCo. 2025;19(1):73\u20137.","journal-title":"MakhillpublicationsCo"},{"key":"892_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6817325","volume":"2016","author":"CR Ojha","year":"2016","unstructured":"Ojha CR, Shakya G, Dumre SP. Virological and Immunological Status of the People Living with HIV\/AIDS Undergoing ART Treatment in Nepal. Biomed Res Int. 2016;2016:1\u20137.","journal-title":"Biomed Res Int"},{"issue":"2","key":"892_CR36","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1097\/QAD.0000000000002983","volume":"35","author":"K Heath","year":"2021","unstructured":"Heath K, Levi J, Hill A. The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture. Aids. 2021;35(2):S197\u2013203.","journal-title":"Aids"},{"issue":"30","key":"892_CR37","first-page":"1","volume":"104","author":"K Nuredin","year":"2025","unstructured":"Nuredin K, Weldegebreal F, Ayele F, Asefa F. Determinants of virological failure among people living with HIV receiving first-line antiretroviral therapy in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia. Med (United States). 2025;104(30):1\u20138.","journal-title":"Med (United States)"},{"issue":"82","key":"892_CR38","first-page":"1","volume":"20","author":"A Endalamaw","year":"2020","unstructured":"Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H, Habtewold TD. HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20(82):1\u201312.","journal-title":"BMC Public Health"},{"key":"892_CR39","unstructured":"WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. Optics InfoBase Conference Papers. 2021. pp. 431\u2013432."},{"issue":"16","key":"892_CR40","first-page":"1","volume":"15","author":"F Li\u00e9geois","year":"2012","unstructured":"Li\u00e9geois F, Vella C, Eymard-Duvernay S, Sica J, Makosso L, Mouinga-Ond\u00e9m\u00e9 A, et al. Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;15(16):1\u20138.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"892_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0116144","volume":"10","author":"K Jobanputra","year":"2015","unstructured":"Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS ONE. 2015;10(2):1\u201312.","journal-title":"PLoS ONE"},{"issue":"4","key":"892_CR42","first-page":"1","volume":"1","author":"T Heestermans","year":"2016","unstructured":"Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Heal. 2016;1(4):1\u201313.","journal-title":"BMJ Glob Heal"},{"issue":"9849","key":"892_CR43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","volume":"380","author":"RK Gupta","year":"2012","unstructured":"Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DHJ, Gregson J, et al. Global trends in antiretroviral resistance in treatment-na\u00efve individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012;380(9849):1250\u20138.","journal-title":"Lancet"},{"key":"892_CR44","unstructured":"Mccomsey GA, Godfrey C, Aweeka F. Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis Adv Access. 2015;1\u201332."},{"key":"892_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20503121211030182","volume":"9","author":"M Desalegn","year":"2021","unstructured":"Desalegn M, Seyoum D, Tola EK, Tsegaye Gayesa R. Determinants of first-line antiretroviral treatment failure among adult HIV patients at Nekemte Specialized Hospital, Western Ethiopia: unmatched case-control study. SAGE Open Med. 2021;9:1\u201311.","journal-title":"SAGE Open Med"},{"issue":"1","key":"892_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-53569-0","volume":"14","author":"NS Muhie","year":"2024","unstructured":"Muhie NS. Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study. Sci Rep. 2024;14(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"308","key":"892_CR47","first-page":"1","volume":"14","author":"I Yaya","year":"2014","unstructured":"Yaya I, Landoh DE, Saka B, Patchali PM, Wasswa P, Aboubakari AS, et al. Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokod\u00e9, Togo. BMC Public Health. 2014;14(308):1\u201310.","journal-title":"BMC Public Health"},{"key":"892_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-8-42","volume":"8","author":"N Khienprasit","year":"2011","unstructured":"Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K. Incidence and risk factors of antiretroviral treatment failure in treatment-na\u00efve HIV-infected patients at Chiang Mai University Hospital, Thailand. AIDS Res Ther. 2011;8:1\u20137.","journal-title":"AIDS Res Ther"},{"key":"892_CR49","doi-asserted-by":"crossref","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Erratum. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (Annals of Internal Medicine (2000) 133 (21\u201330)). Ann Intern Med. 2002;133(3):21\u201330.","DOI":"10.7326\/0003-4819-133-1-200007040-00004"},{"issue":"11","key":"892_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-Reported Barriers to Adherence to Antiretroviral Therapy: a Systematic Review and Meta-Analysis. PLoS Med. 2016;13(11):1\u201314.","journal-title":"PLoS Med"},{"issue":"5","key":"892_CR51","first-page":"1","volume":"19","author":"TG Fuge","year":"2022","unstructured":"Fuge TG, Tsourtos G, Miller ER. Factors affecting optimal adherence to antiretroviral therapy and viral suppression amongst HIV-infected prisoners in South Ethiopia: a comparative cross-sectional study. AIDS Res Ther. 2022;19(5):1\u201314.","journal-title":"AIDS Res Ther"},{"key":"892_CR52","unstructured":"Levitt D, Lillie T, Long-Term HIV. Treatment Adherence for Key Populations: Program Considerations. 2020. pp. 1\u2013142."},{"issue":"7","key":"892_CR53","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s10461-021-03568-3","volume":"26","author":"O Ibiloye","year":"2022","unstructured":"Ibiloye O, Masquillier C, Jwanle P, Van Belle S, van Olmen J, Lynen L, et al. Community-Based ART Service Delivery for Key Populations in Sub-Saharan Africa: scoping Review of Outcomes Along the Continuum of HIV Care. AIDS Behav. 2022;26(7):2314\u201337.","journal-title":"AIDS Behav"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00892-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00892-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:02:24Z","timestamp":1781110944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00892-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["892"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00892-3","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,10]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from Oromia Health Bureau to conduct this retrospective study. Permission letter was obtained from selected health facilities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}